Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

8 results
Display

Pleiotropic Effect of Dronedarone Beyond Antiarrhythmic Agent: Reduction of Hypertrophy

Cha JJ

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Requirements of a Usable Scoring System for Risk Stratification in Patients With Coronary Artery Disease

Kim SS, Kim HK

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preserving the Right Ventricular Function: Early Rhythm Control Through Ablation of Persistent Atrial Fibrillation

Jung MS, Park HS

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cardiomyopathy Without Amyloid Deposit in Systemic Light Chain Deposition Disease

Park BE, Jang SY, Park YJ, Bae MH, Lee JH, Yang DH, Park HS, Cho Y

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Beta Blockers in Contemporary Cardiology: Is It Better to Cast Them Out?

Dar JA, Jacob JR

Beta blockers are one of the commonest prescription drugs in medicine and they have been thought to revolutionize the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dronedarone Attenuates Ang II-Induced Myocardial Hypertrophy Through Regulating SIRT1/FOXO3/PKIA Axis

Chen C, Hu S, Hu HJ, Liu ZX, Wu XT, Zou T, Su H

Background and Objectives: Long-term pathological myocardial hypertrophy (MH) seriously affects the normal function of the heart. Dronedarone was reported to attenuate left ventricular hypertrophy of mice. However, the molecular regulatory...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Radiofrequency Catheter Ablation for Atrial Fibrillation on Right Ventricular Function

Kim M, Uhm JS, Park JW, Bae S, Jung IH, Heo SJ, Kim D, Yu HT, Kim TH, Joung B, Lee MH

Background and Objective: The effects of radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) on right ventricular (RV) function are not well known. Methods: Patients who underwent RFCA for AF and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention

Song PS, Seong SW, Kim JY, An SY, Kim MJ, Ahn KT, Jin SA, Jeong JO, Yang JH, Hahn JY, Gwon HC, Jang WJ, Yoon HJ, Bae JW, Choi WG, Song YB

Background and Objectives: Concerns remain that early aspirin cessation may be associated with potential harm in subsets at high risk of ischemic events. This study aimed to assess the effects...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr